Low density lipoprotein receptor-dependent prostaglandin synthesis in Swiss 3T3 cells stimulated by platelet-derived growth factor.
We studied the effects of human plasma lipoproteins on the synthesis of prostaglandin (PG) E2 in Swiss 3T3 mouse fibroblasts. Quiescent cells, maintained in medium deficient in both platelet-derived growth factor (PDGF) and lipoproteins, synthesized less than 8 ng of PGE2 per 10(6) cells per 22 hr, and this rate did not change in response to the addition of lipoproteins. In contrast, PDGF-stimulated cells, incubated in medium deficient in lipoproteins, synthesized 45-110 ng of PGE2 per 10(6) cells during the same period of time, and this rate increased 2- to 5-fold in the presence of added low density lipoproteins (LDL). This stimulatory effect of LDL seemed to depend on LDL receptor-mediated binding, uptake, and degradation of the lipoproteins because: both LDL and very low density lipoproteins were active, whereas high density lipoproteins were not; low concentrations of LDL were effective; the effect of native LDL was blocked by acetylation of the LDL; PDGF increased both the expression of LDL receptors and the cellular uptake of LDL; chloroquine blocked the effect of LDL but not that of exogenous arachidonic acid. These results provide evidence that the LDL pathway is critically linked to PG synthesis in PDGF-stimulated cells.
Habenicht
A J
AJ
Dresel
H A
HA
Goerig
M
M
Weber
J A
JA
Stoehr
M
M
Glomset
J A
JA
Ross
R
R
Schettler
G
G
D000107:Acetylation; D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D002460:Cell Line; D002738:Chloroquine / Q000494:pharmacology; D015232:Dinoprostone; D004705:Endocytosis / Q000187:drug effects; D007700:Kinetics; D008077:Lipoproteins, LDL / Q000378:metabolism / Q000494:pharmacology; D008079:Lipoproteins, VLDL / Q000494:pharmacology; D008247:Lysosomes / Q000502:physiology; D051379:Mice; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D011453:Prostaglandins / Q000096:biosynthesis*; D011458:Prostaglandins E / Q000096:biosynthesis; D011973:Receptors, LDL / Q000502:physiology*; D013329:Structure-Activity Relationship
D001095:Arachidonic Acids; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D010982:Platelet-Derived Growth Factor; D011453:Prostaglandins; D011458:Prostaglandins E; D011973:Receptors, LDL; D016718:Arachidonic Acid; D002738:Chloroquine; D015232:Dinoprostone